These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 33459726)

  • 41. The hypercoagulable state in COVID-19: Incidence, pathophysiology, and management.
    Abou-Ismail MY; Diamond A; Kapoor S; Arafah Y; Nayak L
    Thromb Res; 2020 Oct; 194():101-115. PubMed ID: 32788101
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Prevention of venous thromboembolism and haemostasis monitoring in patients with COVID-19: Updated proposals (April 2021): From the French working group on perioperative haemostasis (GIHP) and the French study group on thrombosis and haemostasis (GFHT), in collaboration with the French society of anaesthesia and intensive care (SFAR).
    Godon A; Tacquard CA; Mansour A; Garrigue D; Nguyen P; Lasne D; Testa S; Levy JH; Albaladejo P; Gruel Y; Susen S; Godier A;
    Anaesth Crit Care Pain Med; 2021 Aug; 40(4):100919. PubMed ID: 34182166
    [No Abstract]   [Full Text] [Related]  

  • 43. Prothrombotic Milieu, Thrombotic Events and Prophylactic Anticoagulation in Hospitalized COVID-19 Positive Patients: A Review.
    Cryer MJ; Farhan S; Kaufmann CC; Jäger B; Garg A; Krishnan P; Mehran R; Huber K
    Clin Appl Thromb Hemost; 2022; 28():10760296221074353. PubMed ID: 35068227
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Nuts and bolts of COVID-19 associated coagulopathy: the essentials for management and treatment.
    Lindsay PJ; Rosovsky R; Bittner EA; Chang MG
    Postgrad Med; 2021 Nov; 133(8):899-911. PubMed ID: 34470540
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Pediatric issues in thrombosis and hemostasis: The how and why of venous thromboembolism risk stratification in hospitalized children.
    Branchford BR; Betensky M; Goldenberg NA
    Thromb Res; 2018 Dec; 172():190-193. PubMed ID: 29472108
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The Impact of Anticoagulation on COVID-19 (SARS CoV-2) Patient Outcomes: A Systematic Review.
    Lazaridis D; Leung S; Kohler L; Smith CH; Kearson ML; Eraikhuemen N
    J Pharm Pract; 2022 Dec; 35(6):1000-1006. PubMed ID: 33960219
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Systemic thrombosis in a large cohort of COVID-19 patients despite thromboprophylaxis: A retrospective study.
    Muñoz-Rivas N; Abad-Motos A; Mestre-Gómez B; Sierra-Hidalgo F; Cortina-Camarero C; Lorente-Ramos RM; Torres-Rubio P; Arranz-García P; Franco-Moreno AI; Gómez-Mariscal E; Mauleón-Fernández C; Alonso-García S; Rogado J; Saez-Vaquero T; Such-Diaz A; Ryan P; Moya-Mateo E; Martín-Navarro JA; Hernández-Rivas JA; Torres-Macho J; Churruca J;
    Thromb Res; 2021 Mar; 199():132-142. PubMed ID: 33503547
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Practice guidelines of thromboprophylaxis and management of anticoagulation in hospitalized patients with COVID-19].
    ; ; ; ;
    Zhonghua Yi Xue Za Zhi; 2023 Mar; 103(12):863-885. PubMed ID: 36973215
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Physician experiences in management of COVID-19-associated coagulopathy in pregnancy: Communication from the ISTH SSC Subcommittee on Women's Health Issues in Thrombosis and Haemostasis.
    Jevtic SD; Malinowski AK; Othman M; Abdul Kadir RA
    J Thromb Haemost; 2021 Oct; 19(10):2539-2545. PubMed ID: 34260818
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Systematic assessment of venous thromboembolism in COVID-19 patients receiving thromboprophylaxis: incidence and role of D-dimer as predictive factors.
    Artifoni M; Danic G; Gautier G; Gicquel P; Boutoille D; Raffi F; Néel A; Lecomte R
    J Thromb Thrombolysis; 2020 Jul; 50(1):211-216. PubMed ID: 32451823
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The vascular side of COVID-19 disease. Position paper of the International Union of Angiology.
    Costanzo L; Failla G; Antignani PL; Fareed J; Gu Y; Pitha J; Aluigi L; Karplus T; Mansilha A
    Int Angiol; 2020 Dec; 39(6):445-451. PubMed ID: 32892615
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Children and young adults hospitalized for severe COVID-19 exhibit thrombotic coagulopathy.
    Mitchell WB; Davila J; Keenan J; Jackson J; Tal A; Morrone KA; Silver EJ; O'Brien S; Manwani D
    Pediatr Blood Cancer; 2021 Jul; 68(7):e28975. PubMed ID: 33661561
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The 2023 Belgian clinical guidance on anticoagulation management in hospitalized and ambulatory COVID-19 patients.
    Vanassche T; Engelen MM; Orlando C; Vandenbosch K; Gadisseur A; Hermans C; Jochmans K; Minon JM; Motte S; Peperstraete H; Péters P; Sprynger M; Lancellotti P; Dehaene I; Emonts P; Vandenbriele C; Verhamme P; Oury C
    Acta Clin Belg; 2023 Dec; 78(6):497-508. PubMed ID: 37548503
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Prevention and management of thrombosis in hospitalised patients with COVID-19 pneumonia.
    Vincent JL; Levi M; Hunt BJ
    Lancet Respir Med; 2022 Feb; 10(2):214-220. PubMed ID: 34838161
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Factors Associated With Risk of Postdischarge Thrombosis in Patients With COVID-19.
    Li P; Zhao W; Kaatz S; Latack K; Schultz L; Poisson L
    JAMA Netw Open; 2021 Nov; 4(11):e2135397. PubMed ID: 34807256
    [TBL] [Abstract][Full Text] [Related]  

  • 56. COVID-19 related thrombosis: A mini-review.
    Cheng NM; Chan YC; Cheng SW
    Phlebology; 2022 Jun; 37(5):326-337. PubMed ID: 35403487
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Venous Thromboembolism in COVID-19: Towards an Ideal Approach to Thromboprophylaxis, Screening, and Treatment.
    Aryal MR; Gosain R; Donato A; Pathak R; Bhatt VR; Katel A; Kouides P
    Curr Cardiol Rep; 2020 Jun; 22(7):52. PubMed ID: 32529517
    [TBL] [Abstract][Full Text] [Related]  

  • 58. COVID-19-associated coagulopathy and antithrombotic agents-lessons after 1 year.
    Leentjens J; van Haaps TF; Wessels PF; Schutgens REG; Middeldorp S
    Lancet Haematol; 2021 Jul; 8(7):e524-e533. PubMed ID: 33930350
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [COVID-19: Coagulopathy and thrombosis].
    Tazi Mezalek Z
    Rev Med Interne; 2021 Feb; 42(2):93-100. PubMed ID: 33509669
    [TBL] [Abstract][Full Text] [Related]  

  • 60. COVID-19 and immunothrombosis: Pathophysiology and therapeutic implications.
    Lim MS; Mcrae S
    Crit Rev Oncol Hematol; 2021 Dec; 168():103529. PubMed ID: 34800652
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.